NIT
JUNO

NumerixS Investment Technologies’s Juno Therapeutics, Inc. JUNO Stock Holding History

NumerixS Investment Technologies’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-3,500
Closed -$105K – 1454
2017
Q2 		$105K Buy
+3,500
New +$86.4K 0.02% 824
2016
Q2 		– Sell
-18,200
Closed -$693K – 1304
2016
Q1 		$693K Buy
+18,200
New +$634K 0.08% 360

Other funds holding JUNO

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

NumerixS Investment Technologies's JUNO Position: Q3 2017 in Review

NumerixS Investment Technologies sold out of Juno Therapeutics, Inc. (JUNO) in Q3 2017, closing a stake of 3,500 shares — an estimated $105K sold.

NumerixS Investment Technologies first reported a position in JUNO in Q1 2016 and held it in 2 quarters. The position peaked at $693K in Q1 2016. 210 funds tracked by Wall St. Rank hold JUNO as of Q3 2017.

  • NumerixS Investment Technologies reported no remaining Juno Therapeutics, Inc. position as of Q3 2017 after selling out during the quarter.
  • NumerixS Investment Technologies sold 3,500 Juno Therapeutics, Inc. shares in Q3 2017, an estimated $105K.
  • NumerixS Investment Technologies first reported a position in Juno Therapeutics, Inc. in Q1 2016 and held it in 2 quarters.
  • NumerixS Investment Technologies's Juno Therapeutics, Inc. position peaked at $693K in Q1 2016.
  • 210 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q3 2017.

Based on NumerixS Investment Technologies's 13F filing for Q3 2017, filed 13 Nov 2017.